Figure 1From: Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort studyStudy design. AKI, acute kidney injury (defined according to RIFLE criteria); CMS, colistin methanesulfonate sodium; NAs, nephrotoxic antibiotics (aminoglycosides, glycopeptides); Pts, patientsBack to article page